Siste oppdatering :
19/11/2024
Antibiotika   Amoxicillin sodium  
Injeksjon
Oppløsningsstabilitet Stabilitet i blandinger Faktorer som påvirker stabiliteten Kompatibilitet Administrasjonsmåte Referanser pdf
   Kjemisk struktur  

Handelsnavn   Handelsnavn     

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent

Alfoxil Tyrkia
Allmox India
Amitron Spania
Amocillin Sør-Afrika
Amodex Marokko
Amofluxin Egypt
Amoxicilin Peru, Storbritannia
Amoxicillina Italia
Amoxidal Argentina, Peru
Amoxil Australia, Egypt, Hellas, Irland, Marokko, Portugal, Saudi-Arabia, Storbritannia, Tunisia
Aximycine Marokko, Tunisia
Bactox Frankrike, Marokko
Biomox Egypt
Clamoxyl Belgia, Frankrike, Luxembourg, Marokko, Nederland, Spania, Sveits
Darzitil Argentina
E-Mox Egypt
Farconcil Egypt
Fisamox Australia
Flemoxin Nederland
Glymox Plus India
Ibiamox Italia, New Zealand
Klomox India
Largopen Tyrkia
Magcil India
Mixcilin Argentina
Moxacin Australia
Moxilen Tunisia
Moxynil Egypt
Novabritine Luxembourg
Pamocil Italia
Penamox Marokko, Mexico
Simplamox Italia
Velamox Italia
Referanser   Injeksjon   Referanser : Amoxicillin sodium  
Type publikasjon
186 Journal Swart EL, Mooren RAG, Van Loenen AC.
Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
427 Journal Concannon J, Lovitt H, Ramage M, Tai LH, McDonald C, Sunderland VB.
Stability of aqueous solutions of amoxicillin sodium in the frozen and liquid states.
Am J Hosp Pharm 1986 ; 43: 3027-3030.
598 Journal Mc Donald C, Sunderland VB, Lau H, Shija R.
The stability of amoxycillin sodium in normal saline and glucose (5%) solutions in the liquid and frozen states.
J Clin Pharm Ther 1989 ; 14: 45-52.
889 Journal Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM.
Ofloxacin intravenous. Compatibility with other antibacterial agents.
Pharm Weekbl [Sci] 1991 ; 13: 207-209.
939 Journal Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170.
1333 Journal Cook B, Hill SA, Lynn B.
The stability of amoxycillin sodium in intravenous infusion fluids.
J Clin Hosp Pharm 1982 ; 7: 245-250.
1357 Journal Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM.
Quinolones and penicillins incompatibility.
Ann Pharmacotherapy 1989 ; 23: 91-92.
1845 Journal Müller HJ, Haker I.
The stability of amoxicillin, ampicillin, benzylpenicillin, flucloxacillin, mezlocillin and piperacillin in isotonic saline solutions when stored in an innovative infusion container (Freeflex container).
EJHP 2003 ; 6: 106-111.
1888 Journal Janknegt R, Van den Berg TJ, De Jong M, Oldenhof HGJ, Steenhoek A.
Compatibility study of midazolam.
Ziekenhuisfarmacie 1986 ; 2: 45-48.
2349 Journal Pourroy B, Milano Bausset E, Boulamery A, Gauthier Villano L, Braguer B.
Incompatibility of imipenem–cilastatin and amoxicillin
Am J Health-Syst Pharm 2009 ; 66: 1253-1254.
3227 Journal Simon B, Hancu G, Gy?resi A.
Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives
Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520 Labratorium Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3527 Labratorium Amoxicillin (Amoxil®) – Summary of Product Characteristics
Glaxo Smith Kline 2018
3529 Labratorium Ciprofloxacin – Summary of Product Characteristics
Hospira 2013
3549 Labratorium Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3564 Labratorium Rocuronium B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3643 Labratorium Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3674 Labratorium Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3728 Journal Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3777 Journal Patel R.P, Li K, Shastri M, Wanandy T, Jose M.D.
Stability of ampicillin and amoxicillin in peritoneal dialysis solutions
Am J Health-Syst Pharm 2015 ; 72:13-14
4211 Journal Binson G, Grignon C, Le Moal G, Lazaro P, Lelong J, Roblot F, Venisse N, Dupuis A.
Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps.
PlosOne 2019
4254 Journal D'Huart E, Vigneron J, Demoré B.
Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs
Pharmaceutical Technology in Hospital Pharmacy 2019 ;4,1:29-40
4634 Journal Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A.
Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy.
Antibiotics 2022 ;11,4: 458
4654 plakat Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R.
Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables.
Communication personnelle 2021
4837 Journal De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T.
Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings.
Eur J Clin Pharmacol 2024 ; 80:1079–1087.

  Mentions Légales